NeueHealth Statistics
Share Statistics
NeueHealth has 8.25M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 8.25M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 369 |
| FTD / Avg. Volume | 1.11% |
Short Selling Information
The latest short interest is 13.66K, so 0.16% of the outstanding shares have been sold short.
| Short Interest | 13.66K |
| Short % of Shares Out | 0.16% |
| Short % of Float | 0.47% |
| Short Ratio (days to cover) | 1.77 |
Valuation Ratios
The PE ratio is -0.06 and the forward PE ratio is -0.43.
| PE Ratio | -0.06 |
| Forward PE | -0.43 |
| PS Ratio | 0.06 |
| Forward PS | 0.1 |
| PB Ratio | -0.19 |
| P/FCF Ratio | -0.02 |
| PEG Ratio | n/a |
Enterprise Valuation
NeueHealth Inc. has an Enterprise Value (EV) of 348.67M.
| EV / Earnings | -0.3 |
| EV / Sales | 0.3 |
| EV / EBITDA | -0.62 |
| EV / EBIT | -0.6 |
| EV / FCF | -0.13 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of -1.1.
| Current Ratio | 0.78 |
| Quick Ratio | 0.78 |
| Debt / Equity | -1.1 |
| Total Debt / Capitalization | 1.11K |
| Cash Flow / Debt | -7.22 |
| Interest Coverage | -15.1 |
Financial Efficiency
Return on equity (ROE) is 3.35% and return on capital (ROIC) is -497.44%.
| Return on Equity (ROE) | 3.35% |
| Return on Assets (ROA) | -0.94% |
| Return on Capital (ROIC) | -497.44% |
| Revenue Per Employee | 927.16K |
| Profits Per Employee | -919.69K |
| Employee Count | 1.25K |
| Asset Turnover | 0.95 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -1.43M |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -31.11% in the last 52 weeks. The beta is 0.77, so NeueHealth 's price volatility has been higher than the market average.
| Beta | 0.77 |
| 52-Week Price Change | -31.11% |
| 50-Day Moving Average | 5.57 |
| 200-Day Moving Average | 5.59 |
| Relative Strength Index (RSI) | 67.84 |
| Average Volume (20 Days) | 33.20K |
Income Statement
In the last 12 months, NeueHealth had revenue of 1.16B and earned -1.15B in profits. Earnings per share was -150.94.
| Revenue | 1.16B |
| Gross Profit | 164.22M |
| Operating Income | -577.00M |
| Net Income | -1.15B |
| EBITDA | -566.80M |
| EBIT | -577.00M |
| Earnings Per Share (EPS) | -150.94 |
Balance Sheet
The company has 87.30M in cash and 370.35M in debt, giving a net cash position of -283.05M.
| Cash & Cash Equivalents | 87.30M |
| Total Debt | 370.35M |
| Net Cash | -283.05M |
| Retained Earnings | -4.31B |
| Total Assets | 696.78M |
| Working Capital | -283.01M |
Cash Flow
In the last 12 months, operating cash flow was -2.73B and capital expenditures -2.90M, giving a free cash flow of -2.73B.
| Operating Cash Flow | -2.73B |
| Capital Expenditures | -2.90M |
| Free Cash Flow | -2.73B |
| FCF Per Share | -343.15 |
Margins
Gross margin is 14.15%, with operating and profit margins of -49.71% and -99.19%.
| Gross Margin | 14.15% |
| Operating Margin | -49.71% |
| Pretax Margin | -54.2% |
| Profit Margin | -99.19% |
| EBITDA Margin | -48.83% |
| EBIT Margin | -49.71% |
| FCF Margin | -235.13% |
Dividends & Yields
NEUE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2059.21% |
| FCF Yield | -4511.11% |
Analyst Forecast
The average price target for NEUE is $7, which is -4.5% lower than the current price. The consensus rating is "Hold".
| Price Target | $7 |
| Price Target Difference | -4.5% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Stock Splits
The last stock split was on May 22, 2023. It was a backward split with a ratio of 1:80.
| Last Split Date | May 22, 2023 |
| Split Type | backward |
| Split Ratio | 1:80 |
Scores
| Altman Z-Score | -8.39 |
| Piotroski F-Score | 2 |